Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2026-02-21 @ 11:19 PM
Study NCT ID:
NCT01404104
Status:
COMPLETED
Last Update Posted:
2016-07-27
First Post:
2011-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neo-adjuvant Temsirolimus in Patients With Advanced Renal Cell Carcinoma
Sponsor:
St. Joseph's Healthcare Hamilton
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IIS-003-09
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None